In vitrocombinations of natamycin with voriconazole, itraconazole and micafungin against clinicalFusariumstrains causing keratitis: Table 1.

Filamentous fungal infections of the cornea: a global overview of epidemiology and drug sensitivity

(2015) László Kredics et al.   MYCOSES

Keratitis by Fusarium temperatum, a novel opportunist

(2014) Abdullah M S Al-Hatmi et al.   BMC INFECTIOUS DISEASES

Life expectancy following orbital exenteration

(2014) James Chiun Lon Wong et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex

(2014) A. M. S. Al-Hatmi et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Association between In Vitro Susceptibility to Natamycin and Voriconazole and Clinical Outcomes in Fungal Keratitis

(2014) Catherine Q. Sun et al.   OPHTHALMOLOGY

Synergysm of voriconazole or itraconazole with other antifungal agents against species of Fusarium

(2013) Tatiana B. Spader et al.   REVISTA IBEROAMERICANA DE MICOLOGIA

Early Keratectomy in the Treatment of Moderate Fusarium Keratitis

(2012) Hsin-Chiung Lin et al.   PLoS One

The Mycotic Ulcer Treatment Trial

(2012) N. Venkatesh Prajna et al.   JAMA Ophthalmology

Less-Frequent Fusarium Species of Clinical Interest: Correlation between Morphological and Molecular Identification and Antifungal Susceptibility

(2009) M. Azor et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In Vitro Evaluation of Combination Antifungal Activity against Fusarium Species Isolated from Ocular Tissues of Keratomycosis Patients

(2008) Li Li et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Voriconazole in the treatment of fungal eye infections: a review of current literature

(2008) S M Hariprasad et al.   BRITISH JOURNAL OF OPHTHALMOLOGY